Dismenorrea primaria: visión actual

Autores/as

  • Alvaro Monterrosa Castro

DOI:

https://doi.org/10.18597/rcog.700

Resumen

Con el adelanto alcanzado en el conocimiento de todos los aspectos relacionados con la dismenorrea primaria, hoy día se dispone de sustancias y esquemas de tratamiento farmacológico, encaminados a aliviar e incluso prevenir las manifestaciones dolorosas que genera esta condición femenina. Se presentan en la siguiente revisión los conceptos actuales que explican los eventos involucrados en la fisiopatología, y se señalan y detallan consideraciones propias con respecto a los benéficos que generan los AINES y los anticonceptivos orales combinados, que son las medidas terapéuticas que se deben utilizar. Se presentan las medidas alternativas de manejo que se han venido postulando en los últimos años.

La severidad del dolor pélvico durante la fase menstrual, definido como dismenorrea primaria, puede minizarse si el profesional de la salud, tiene una visión clara de la fisiopatología de esta condición, si provee información y educación a sus pacientes con respecto a los aspectos relacionados, y si recomienda y estimula el uso profiláctico de los diferentes agentes que inhiben o impiden la síntesis de prostaglandinas, mientras contribuye a erradicar los mitos presentes en la comunicad, que impiden la correcta comprensión y la toma de medidas verdaderamente eficaces.

Biografía del autor/a

Alvaro Monterrosa Castro

Profesor Titular. Departamento de Ginecología y Obstetricia. Facultad de Medicina. Universidad de Cartagena.

Referencias bibliográficas

Chen C, Cho S, Damoskosh Al. Prospective study of exposure to environmental tobacco smoke and dysmenorrhea. Environ Health Perspect 2000; 108 (11): 1019-1022.

Wilson ML, Farquhar CM, Sinclair OJ. Surgical interruption of pelvic nerve Pathways for primary and secondary dysmenorrhea. Cochrane Database Syst Rev 2000; (2): CD001896.

Morrison B, Daniel S, Kotey P, et al. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dismenorrhea: A Randomized controlled trial. Obstet Gynecol 1999; 94(4): 504-508.

Schroeder B, Sanfilippo J. Dysmenorrhea and pelvic pain in adolescents. Pediatrics Clinics of North America. 1999; 46(3): 555-571.

Dawood MY. Dismenorrea. Clínicas Obstétricas y Ginecológicas. 1990; 1: 167-176.

Mish PC (eds): Webster's Ninth New Collegiate Dictionary, Springfield, Massachussettz, Merriam-Webster Inc, 1986; 331.

Smith Rp. Dolor pélvico cíclico y dismenorrea. Clínicas de Ginecología y Obstetricia Temas Actuales. 1993: 4: 739-750.

Jacobson E, Lackner JE, Sinykin. Electrical and mechanical activity of the human non-pregnancy uterus. AM J Obstet Gynecol 1939; 38: 1008-1011.

Liessé A. L'áctivite electrique de l'úterus dans la dysmenorrhea functionalle. Gynecol et Obstett. 1948; 47: 850-854.

Woodbury RA, Torpin R, Child GP, et al. Miometrial physiology and its relation to pelvic pain. JAMA 1947; 134: 1081.

Dawood MY, Ramos J. Transcutaneous electrical nerve simulation (TENS) for the treatment of primary dysmenorrhea. A randomized crossover comparison with placebo, TENS and ibuprofen. Obstet Gynecol, 1190; 75: 656-662.

Pickles VR, Hall WJ, Best FA. Prostaglandin's in endometrium and menopausal fluid from normal and dysmenorrhea subjects. J Obstet Gynecol Br Comm. 1965; 72: 185-193.

Pickles VR. Prostaglandin's and dysmenorrhea: historical survey. Act Obstet Gynecol Scand 1979; 87 (suppl): 58: 7-12.

Dawood MY. Dysmenorrhea and Prostaglandin's: Pharmacological and therapeutic considerations. Drugs 1981; 22: 42-52.

Sánchez F. Dismenorrea. IN: Botero J, Jubiz A, Henao G. Obstetricia y Ginecología. Texto integrado 6a Edición. Medellín 1999.

Akerlund M, Stromberg P, Forling MD. Primary dysmenorrhea and vasopresin. Br J Obstet Gynecol 1979; 86: 184-192.

Brouard R, Bossmar T, Fournie-Loret D, et al. Effects of SR49059, an orally active V1a vasopresin receptor antagonist, in the prevention of dysmenorrhea. BJOG 2000; 107(5): 614-619.

Valentin L, Sladkevicius P, Kindahl H, et al. Effect of a vasopresin antagonist in women with dysmenorrhea. Gynecol Obstet Invest 2000; 50(3) 170-177.

Wiener J. Chronic pelvic pain. Practitioner 1994; 238: 352-355.

Abu JL, Konje JC. Leukotrienes in gynecology: the hypothetical value of anti- Leukotrienes therapy in dysmenorrhea and endometriosis. Hum Reprod Update. 2000; 6(2): 200-205.

Harel Z, Lilly C, Riggs S, et al. Urinary Leukotrienes (LT3 4) in adolescents with dysmenorrhea: a pilot study. J Adolesc Health 2000; 27(3): 151-154.

WU D, Wang X, Chen D, et al. Metabolic gene plymorphism's and risk of dysmenorrhea. Epidemiology 2000; 11(6): 648-653.

Maya RA, Moisa CF, Morales F, et al. Transdermal glyceryl trinitrate in the management of primary dysmenorrhea. Int J Gynecol Obstet 2000: 69(2): 113-118.

Mathias SD, Kuppermann M, Liberman RF, et al. Chronic pelvic pain: prevalence, health related quality of life and economics correlates. Obstet Gynecol 1996; 87: 321-327.

Nolan TE, Elkins TE. Chronic pelvic pain. Differentiating anatomic from functional causes. Postgrad Med. 1993; 94: 125-128.

Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996; 1: 55-59.

Mahmood TA, Templeton AA, Thomsom L, et al. Menstrual symptoms in women with pelvic endometriosis. Br J Obstet Gynecol 1991; 98: 558-563.

Warner T, Giuliano F, Voinovic I, et al. Nonsteroid drug selectivity's for cyclo-oxigenase-1 rather than cyclo-oxigenase 2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl. Acad Sci. 1999; 96: 7563-7568.

Fry RP, Crisp AH, Beard RW, et al. Psychosocial aspects of chronic pelvic pain, with special reference to sexual abuse. A study of 164 women. Postgrad Med J 1993; 69: 566-574.

Waller KG, Shaw RW. Endometriosis, pelvic pain and psychological functioning. Fertil Steril 1995; 63: 566-574.

Zondervan K, Yudkin P, Vessey MP. The prevalence of chronic pelvic pain in women in the United Kingdom: A systematic review. Br J Obstet Gynecol 1998; 105: 93-99.

Beard RW, Reginald PW. Chronic pelvic pain. IN: Shaw RW, Soutter P, Stanton SI (Eds). Gynecology. Edinburgh. Churchill Livingstone 1992: 777-789.

Monterrosa A. Dolor pélvico crónico: Diagnóstico diferencial. Selecta Médica. 1997; 8(1): 26-29.

Wilson C, Emans SJ, Mansfield J, et al. The relationship of calculated percent boy fat, sports participation, age, and place of residence on menstrual patterns in healthy adolescent girls at an independent. New England high school. J Adolesc Health Care. 1984; 5: 248-253.

Harlow S, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstetric and Gynaecol 1996; 103: 1134 - 1142.

Dmitrovic R. Transvaginal color Doppler study of uterine blood flow in primary dysmenorrhea. Act Obstet Gynecol Scand 2000; 79 (12): 1112-1116.

Jay MS, Durant RH, Shoffitt T, et al. Differential response by adolescents to naproxen sodium therapy for spasmodic and congestive dysmenorrhea. J Adolesc Health Care 1986; 7 (6): 395-400.

Dawood MY. Dysmenorrhea. J Reprod Med. 1985; 30: 154-162.

Balbi C, Musone R, Menditto A, et al. Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. Eur J Obstet Gynecol Reprod Biol. 2000; 91(2): 143-148.

Herel Z, Biro F, Kottnhahn R, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996; 174: 1335 - 1338.

Davies L, Gangar KF, Drummond M, et al. The economic burden of intractable gynecological pain. J Obstet Gynecol 1992; 12 (S): 54-56.

Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhea in young women. Br J Obstet Gynecol 1990; 97: 588-594.

Dawood My. Ibuprofen and dysmenorrhea. Am J Med. 1984; 77: 87-92.

Parazzini F, Tozzi L, Mezzopane R, et al. Cigarette smoking, alcohol consumption and risk of primary dysmenorrhea. Epidemiology 1994; 5: 469-472.

Andersch B, Milsom I. An epidemiology study of young women with dysmenorrhea. Am J Obstet Gynecol 1982; 144: 655-661.

Harlow SD, Matanoski GM. The association between weight, physical activity and stress and variation in the length of the menstrual cycle. Am J Epidemiol 1991; 133: 38-49.

Sulak P, Ceressman B, Waldrop E, et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997; 89: 179-183.

Zhang WY, Wan P. Efficacy of minor analgesics in primary dysmenorrhea: a systematic review: Br J Obstet Gynecol 1998; 105: 780-789.

Brooks P. Use and benefits of Nonsteroidal anti-inflammatory drugs. Am J Med. 1998; 104(3S): 9-13.

Frohlich JC. Prostaglandin endoperoxide syntethase iso enzymes: the clinical relevance of selective inhibition. Ann Rheum Dis. 1995; 54: 942-943.

Chan WY, Fuchs F, Powel AM. Effects of Naproxen sodium on menstrual prostaglandin's and primary dysmenorrhea. Obstet Gynecol 1983; 61: 285-293.

Monterrosa A. Nuevos conceptos en Anticonceptivos orales combinados. 3a Eds. Bogotá. 2001.

Akin MD, Weingand DA, Hengehold DA, et al. Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol 2001; 97(3): 343-349.

Nezhat CH, Seidman D, Nezhat F, et al. Long term outcome of laparoscopic presacral neurectomy for the treatment of central pelvic pain attributed to endometriosis. Obstet Gynecol 1998; 91: 701-704.

Fang-Ping C, Yung-Kuei S. The efficacy and complications of laparoscopic presacral neurectomy in pelvic pain. Obstet 1997; 90: 974-977.

Kostrzewska A, Lauddañsski T, Batra S. Potent inhibition by tamoxifen of spontaneous and agonist induced contractions of the human myometrium and intramyometrial arteries. Am J Obstet Gynecol 1997; 176: 381-386.

Milsom I, Hedner N, Mannheimer C. A comparative study of the effect o high intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with high primary dysmenorrhea. Am J Obstet Gynecol 1994; 170 (1 pt1): 123-129.

Helms J. Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987; 69: 61-69.

Vercellini P, Aimi G, Panazza S, et al. A Levonorgestrel releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 1999; 72: 505-508.

Pitroff R, Lees C, Thompson C, et al. Crossover study of glyceryl trinitrate patches for controlling pain in women with severe dysmenorrhea. BMJ 1996; 312: 884.

Cómo citar

1.
Monterrosa Castro A. Dismenorrea primaria: visión actual. Rev. Colomb. Obstet. Ginecol. [Internet]. 28 de diciembre de 2001 [citado 2 de julio de 2022];52(4):342-54. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/700

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2001-12-28

Número

Sección

Revisión de Tema

Artículos más leídos del mismo autor/a

1 2 > >>